Susquehanna International Group
ORIC icon

Susquehanna International Group’s Oric Pharmaceuticals ORIC Stock Holding History

Susquehanna International Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-112,700
Closed -$1.35M – 13241
2025
Q3 		$1.35M Buy
112,700
+102,600
+1,016% +$1.08M ﹤0.01% 6629
2025
Q2 		$103K Buy
+10,100
New +$67.8K ﹤0.01% 11783
2023
Q3 		– Sell
-69,900
Closed -$542K – 12692
2023
Q2 		$542K Buy
69,900
+56,800
+434% +$323K ﹤0.01% 8120
2023
Q1 		$74.7K Sell
13,100
-14,200
-52% -$74.2K ﹤0.01% 11491
2022
Q4 		$161K Sell
27,300
-74,400
-73% -$251K ﹤0.01% 10414
2022
Q3 		$325K Sell
101,700
-3,800
-4% -$15.2K ﹤0.01% 9592
2022
Q2 		$473K Buy
+105,500
New +$421K ﹤0.01% 8404

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Susquehanna International Group's ORIC Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 23,055 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #10916 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ORIC as recently as Q3 2025.

Susquehanna International Group first reported a position in ORIC in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.43M in Q2 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Susquehanna International Group held 23,055 shares of Oric Pharmaceuticals worth $292K as of Q1 2026.
  • Oric Pharmaceuticals was a new Susquehanna International Group position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10916 holding.
  • Susquehanna International Group first reported a position in Oric Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • Susquehanna International Group's Oric Pharmaceuticals position peaked at $1.43M in Q2 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.